194 related articles for article (PubMed ID: 36056826)
1. Microbiome-Based Therapies in Parkinson's Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?
Onaolapo AY; Ojo FO; Olofinnade AT; Falade J; Lawal IA; Onaolapo OJ
CNS Neurol Disord Drug Targets; 2022 Sep; ():. PubMed ID: 36056826
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
Front Immunol; 2022; 13():937555. PubMed ID: 35812394
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
4. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
[TBL] [Abstract][Full Text] [Related]
5. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease: Are gut microbes involved?
Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
[TBL] [Abstract][Full Text] [Related]
7. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.
Lorente-Picón M; Laguna A
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33804226
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
[TBL] [Abstract][Full Text] [Related]
9. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
10. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
[TBL] [Abstract][Full Text] [Related]
11. The link between the gut microbiome, inflammation, and Parkinson's disease.
Nie S; Ge Y
Appl Microbiol Biotechnol; 2023 Nov; 107(22):6737-6749. PubMed ID: 37736791
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
13. The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.
Yao L; Yang Y; Yang X; Rezaei MJ
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38587699
[TBL] [Abstract][Full Text] [Related]
14. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
[TBL] [Abstract][Full Text] [Related]
16. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
[TBL] [Abstract][Full Text] [Related]
17. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
18. Probiotics for Parkinson's Disease.
Gazerani P
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
[TBL] [Abstract][Full Text] [Related]
19. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
